SEC Info - Thermo Fisher Scientific Inc.

SEC Info℠

Home

Help

Please Sign In

Thermo Fisher Scientific Inc. – ‘8-K’ for 9/10/20

On: Monday, 9/14/20, at 9:20am ET · For: 9/10/20 · Accession #: 97745-20-45 · File #: 1-08002

  As Of               Filer                 Filing    For·On·As Docs:Size

 9/14/20  Thermo Fisher Scientific Inc.     8-K:5       9/10/20   12:375K

Current Report — Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     45K 
 8: R1          Document and Entity Information                     HTML     88K 
10: XML         IDEA XML File -- Filing Summary                      XML     12K 
 7: XML         XBRL Instance -- tmo-20200910_htm                    XML     78K 
 9: EXCEL       IDEA Workbook of Financial Reports                  XLSX      7K 
 3: EX-101.CAL  XBRL Calculations -- tmo-20200910_cal                XML      7K 
 4: EX-101.DEF  XBRL Definitions -- tmo-20200910_def                 XML     56K 
 5: EX-101.LAB  XBRL Labels -- tmo-20200910_lab                      XML    135K 
 6: EX-101.PRE  XBRL Presentations -- tmo-20200910_pre               XML     58K 
 2: EX-101.SCH  XBRL Schema -- tmo-20200910                          XSD     22K 
11: JSON        XBRL Instance as JSON Data -- MetaLinks               19±    27K 
12: ZIP         XBRL Zipped Folder -- 0000097745-20-000045-xbrl      Zip     21K

‘8-K’ — Current Report

This is an HTML Document rendered as filed. [ Alternative Formats ]

iX: C: C:

tmo-20200910

i 0000097745 i FALSE00000977452020-09-102020-09-100000097745us-gaap:CommonStockMember2020-09-102020-09-100000097745tmo:SeniorNotesFloatingRateDue2020Member2020-09-102020-09-100000097745tmo:SeniorNotes2.15Due2022Member2020-09-102020-09-100000097745tmo:SeniorNotes0.75Due2024Member2020-09-102020-09-100000097745tmo:SeniorNotes0.125Due2025Member2020-09-102020-09-100000097745tmo:SeniorNotes200Due2025Member2020-09-102020-09-100000097745tmo:SeniorNotes1.40Due2026Member2020-09-102020-09-100000097745tmo:A1.45SeniorNotesDue2027Member2020-09-102020-09-100000097745tmo:SeniorNotes175Due2027Member2020-09-102020-09-100000097745tmo:SeniorNotes0.500Due2028Member2020-09-102020-09-100000097745tmo:SeniorNotes1.375Due2028Member2020-09-102020-09-100000097745tmo:SeniorNotes1.95Due2029Member2020-09-102020-09-100000097745tmo:SeniorNotes0.875Due2031Member2020-09-102020-09-100000097745tmo:SeniorNotes2375Due2032Member2020-09-102020-09-100000097745tmo:SeniorNotes2.875Due2037Member2020-09-102020-09-100000097745tmo:SeniorNotes1.500Due2039Member2020-09-102020-09-100000097745tmo:SeniorNotes1.875Due2049Member2020-09-102020-09-10

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM i 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): i September 10, 2020

i THERMO FISHER SCIENTIFIC INC.

(Exact name of Registrant as specified in its Charter)

i Delaware

i 1-8002

i 04-2209186

(State of incorporation)

(Commission File Number)

(I.R.S. Employer Identification Number)

i 168 Third Avenue

i Waltham, i Massachusetts i 02451

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: ( i 781) i 622-1000

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

i ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

i ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

i ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

i ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

i Common Stock, $1.00 par value

i TMO

i New York Stock Exchange

i Floating Rate Notes due 2020

i TMO /20A

i New York Stock Exchange

i 2.150% Notes due 2022

i TMO 22A

i New York Stock Exchange

i 0.750% Notes due 2024

i TMO 24A

i New York Stock Exchange

i 0.125% Notes due 2025

i TMO 25B

i New York Stock Exchange

i 2.000% Notes due 2025

i TMO 25

i New York Stock Exchange

i 1.400% Notes due 2026

i TMO 26A

i New York Stock Exchange

i 1.450% Notes due 2027

i TMO 27

i New York Stock Exchange

i 1.750% Notes due 2027

i TMO 27B

i New York Stock Exchange

i 0.500% Notes due 2028

i TMO 28A

i New York Stock Exchange

i 1.375% Notes due 2028

i TMO 28

i New York Stock Exchange

i 1.950% Notes due 2029

i TMO 29

i New York Stock Exchange

i 0.875% Notes due 2031

i TMO 31

i New York Stock Exchange

i 2.375% Notes due 2032

i TMO 32

i New York Stock Exchange

i 2.875% Notes due 2037

i TMO 37

i New York Stock Exchange

i 1.500% Notes due 2039

i TMO 39

i New York Stock Exchange

i 1.875% Notes due 2049

i TMO 49

i New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934. i ☐ Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

THERMO FISHER SCIENTIFIC INC.

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On September 10, 2020, Peter Hornstra, Vice President and Chief Accounting Officer of Thermo Fisher Scientific Inc. (the “Company”), notified the Company that he will retire effective March 31, 2021.

Also on September 10, 2020, the Board of Directors of the Company elected Joseph Holmes, 41, currently Senior Director of Technical Accounting, to the position of Vice President and Chief Accounting Officer of the Company, effective March 31, 2021. Mr. Holmes joined Thermo Fisher in his current role in June 2017 and leads a team that provides a broad range of accounting and finance counsel to the Company’s global finance team. Previously, Mr. Holmes served as Director, Technical Accounting and Reporting at St. Jude Medical, where his responsibilities included oversite of technical accounting, SEC reporting and internal controls, from June 2014 to January 2017, when it was acquired by Abbott Laboratories (“Abbott”), and then continued to serve in that position at Abbott from January 2017 to June 2017.

THERMO FISHER SCIENTIFIC INC.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

THERMO FISHER SCIENTIFIC INC.

Date:

September 14, 2020

By:

/s/ Michael A. Boxer

Michael A. Boxer

Senior Vice President and General Counsel